KRT20 and in situ carcinoma: Despite elevated levels of luminal type markers, including KRT20, class 2 tumors showed poor prognosis, which indicated that class 2 may represent a molecular shift toward muscle-invasive carcinoma by taking the carcinoma in situ (CIS) pathway [6].